|
1
|
Shaw JE, Sicree RA and Zimmet PZ: Global
estimates of the prevalence of diabetes for 2010 and 2030. Diabetes
Res Clin Pract. 87:4–14. 2010. View Article : Google Scholar
|
|
2
|
Guariguata L, Whiting DR, Hambleton I,
Beagley J, Linnenkamp U and Shaw JE: Global estimates of diabetes
prevalence for 2013 and projections for 2035. Diabetes Res Clin
Pract. 103:137–149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bachmann KN and Wang TJ: Biomarkers of
cardiovascular disease: Contributions to risk prediction in
individuals with diabetes. Diabetologia. Sep 28–2017.Epub ahead of
print. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Capellini VK, Celotto AC, Baldo CF, Olivon
VC, Viaro F, Rodrigues AJ and Evora PR: Diabetes and vascular
disease: Basic concepts of nitric oxide physiology, endothelial
dysfunction, oxidative stress and therapeutic possibilities. Curr
Vasc Pharmacol. 8:526–544. 2010. View Article : Google Scholar
|
|
5
|
Taguchi K, Sakata K, Ohashi W, Imaizumi T,
Imura J and Hattori Y: Tonic inhibition by G protein-coupled
receptor kinase 2 of Akt/endothelial nitric-oxide synthase
signaling in human vascular endothelial cells under conditions of
hyperglycemia with high insulin levels. J Pharmacol Exp Ther.
349:199–208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao H, Ma T, Fan B, Han C, Luo J and Kong
L: Protective effect of trans-δ-viniferin against high
glucose-induced oxidative stress in human umbilical vein
endothelial cells through the SIRT1 pathway. Free Radic Res.
50:68–83. 2016. View Article : Google Scholar
|
|
7
|
Zhang Y, Liu T, Chen Y, Dong Z, Zhang J,
Sun Y, Jin B, Gao F, Guo S and Zhuang R: CD226 reduces endothelial
cell glucose uptake under hyperglycemic conditions with
inflammation in type 2 diabetes mellitus. Oncotarget.
7:12010–12023. 2016.PubMed/NCBI
|
|
8
|
Bhatt MP, Lim YC, Hwang J, Na S, Kim YM
and Ha KS: C-peptide prevents hyperglycemia-induced endothelial
apoptosis through inhibition of reactive oxygen species-mediated
transglutaminase 2 activation. Diabetes. 62:243–253. 2013.
View Article : Google Scholar
|
|
9
|
Surico D, Farruggio S, Marotta P, Raina G,
Mary D, Surico N, Vacca G and Grossini E: Human chorionic
gonadotropin protects vascular endothelial cells from oxidative
stress by apoptosis inhibition, cell survival signalling activation
and mitochondrial function protection. Cell Physiol Biochem.
36:2108–2120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Samanta A, Perazzona B, Chakraborty S, Sun
X, Modi H, Bhatia R, Priebe W and Arlinghaus R: Janus kinase 2
regulates Bcr-Abl signaling in chronic myeloid leukemia. Leukemia.
25:463–472. 2011. View Article : Google Scholar
|
|
11
|
Kiu H and Nicholson SE: Biology and
significance of the JAK/STAT signalling pathways. Growth Factors.
30:88–106. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Copf T, Goguel V, Lampin-Saint-Amaux A,
Scaplehorn N and Preat T: Cytokine signaling through the JAK/STAT
pathway is required for long-term memory in Drosophila. Proc Natl
Acad Sci USA. 108:8059–8064. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hiroi T, Wajima T, Kaneko Y, Kiuchi Y and
Shimizu S: An important role of increase intetrahydrobiopterin via
H2O2-JAK2 signaling pathway in late phase of
ischaemic preconditioning. Exp Physiol. 95:609–621. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qi QR and Yang ZM: Regulation and function
of signal transducer and activator of transcription 3. World J Biol
Chem. 5:231–239. 2014.PubMed/NCBI
|
|
15
|
Corcoran RB, Contino G, Deshpande V,
Tzatsos A, Conrad C, Benes CH, Levy DE, Settleman J, Engelman JA
and Bardeesy N: STAT3 plays a critical role in KRAS-induced
pancreatic tumorigenesis. Cancer Res. 71:5020–5029. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aittomäki S and Pesu M: Therapeutic
targeting of the Jak/STAT pathway. Basic Clin Pharmacol Toxicol.
114:18–23. 2014. View Article : Google Scholar
|
|
17
|
Manea SA, Manea A and Heltianu C:
Inhibition of JAK/STAT signaling pathway prevents
high-glucose-induced increase in endothelin-1 synthesis in human
endothelial cells. Cell Tissue Res. 340:71–79. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Amiri F, Venema VJ, Wang X, Ju H, Venema
RC and Marrero MB: Hyperglycemia enhances angiotensin II-induced
janus-activated kinase/STAT signaling in vascular smooth muscle
cells. J Biol Chem. 274:32382–32386. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hao PP, Chen YG, Liu YP, Zhang MX, Yang
JM, Gao F, Zhang Y and Zhang C: Association of plasma
angiotensin-(1-7) level and left ventricular function in patients
with type 2 diabetes mellitus. PLoS One. 8:e627882013. View Article : Google Scholar
|
|
20
|
Reich HN, Oudit GY, Penninger JM, Scholey
JW and Herzenberg AM: Decreased glomerular and tubular expression
of ACE2 in patients with type 2 diabetes and kidney disease. Kidney
Int. 74:1610–1616. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu CX, Hu Q, Wang Y, Zhang W, Ma ZY, Feng
JB, Wang R, Wang XP, Dong B, Gao F, et al: Angiotensin-converting
enzyme (ACE) 2 overexpression ameliorates glomerular injury in a
rat model of diabetic nephropathy: A comparison with ACE
inhibition. Mol Med. 17:59–69. 2011.
|
|
22
|
Benter IF, Yousif MH, Cojocel C,
Al-Maghrebi M and Diz DI: Angiotensin-(1-7) prevents
diabetes-induced cardiovascular dysfunction. Am J Physiol Heart
Circ Physiol. 292:H666–H672. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yousif MH, Dhaunsi GS, Makki BM, Qabazard
BA, Akhtar S and Benter IF: Characterization of Angiotensin-(1-7)
effects on the cardiovascular system in an experimental model of
type-1 diabetes. Pharmacol Res. 66:269–275. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hao PP, Yang JM, Zhang MX, Zhang K, Chen
YG, Zhang C and Zhang Y: Angiotensin-(1-7) treatment mitigates
right ventricular fibrosis as a distinctive feature of diabetic
cardiomyopathy. Am J Physiol Heart Circ Physiol. 308:H1007–H1019.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kandalam U and Clark MA: Angiotensin II
activates JAK2/STAT3 pathway and induces interleukin-6 production
in cultured rat brainstem astrocytes. Regul Pept. 159:110–106.
2010. View Article : Google Scholar
|
|
26
|
Mori J, Patel VB, Ramprasath T, Alrob OA,
DesAulniers J, Scholey JW, Lopaschuk GD and Oudit GY: Angiotensin
1-7 mediates renoprotection against diabetic nephropathy by
reducing oxidative stress, inflammation, and lipotoxicity. Am J
Physiol Renal Physiol. 306:F812–F821. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
28
|
Huanga Z, Zhuanga X, Xieb C, Hua X, Donga
X, Guoa Y, Lic S and Liao X: Exogenous hydrogen sulfide attenuates
high glucose-induced cardiotoxicity by inhibiting NLRP3
inflammasome activation by suppressing TLR4/NF-κB pathway in H9c2
Cells. Cell Physiol Biochem. 40:v1578–v1590. 2016. View Article : Google Scholar
|
|
29
|
Ku SK and Bae JS: Baicalin, baicalein and
wogonin inhibits high glucose-induced vascular inflammation in
vitro and in vivo. BMB Rep. 48:519–524. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chu P, Han G, Ahsan A, Sun Z, Liu S, Zhang
Z, Sun B, Song Y, Lin Y, Peng J and Tang Z: Phosphocreatine
protects endothelial cells from Methylglyoxal induced oxidative
stress and apoptosis via the regulation of PI3K/Akt/eNOS and NF-κB
pathway. Vascul Pharmacol. 91:26–35. 2017. View Article : Google Scholar
|
|
31
|
Wang XM, Song SS, Xiao H, Gao P, Li XJ and
Si LY: Fibroblast growth factor 21 protects against high glucose
induced cellular damage and dysfunction of endothelial nitric-oxide
synthase in endothelial cells. Cell Physiol Biochem. 34:658–671.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cui ZT, Liu JP and Wei WL: The effects of
tanshinone IIA on hypoxia/reoxygenation-induced myocardial
microvascular endothelial cell apoptosis in rats via the JAK2/STAT3
signaling pathway. Biomed Pharmacother. 83:1116–1126. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiang X, Guo CX, Zeng XJ, Li HH, Chen BX
and Du FH: A soluble receptor for advanced glycation end-products
inhibits myocardial apoptosis induced by ischemia/reperfusion via
the JAK2/STAT3 pathway. Apoptosis. 20:1033–1047. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao GL, Yu LM, Gao WL, Duan WX, Jiang B,
Liu XD, Zhang B, Liu ZH, Zhai ME, Jin ZX, et al: Berberine protects
rat heart from ischemia/reperfusion injury via activating
JAK2/STAT3 signaling and attenuating endoplasmic reticulum stress.
Acta Pharmacol Sin. 37:354–367. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li L, Li M, Li Y, Sun W, Wang Y, Bai S, Li
H, Wu B, Yang G, Wang R, et al: Exogenous H2S
contributes to recovery of isch-emic post-conditioning-induced
cardioprotection by decrease of ROS level via down-regulation of
NF-κB and JAK2-STAT3 pathways in the aging cardiomyocytes. Cell
Biosci. 6:262016. View Article : Google Scholar
|
|
36
|
Wu L, Tan JL, Wang ZH, Chen YX, Gao L, Liu
JL, Shi YH, Endoh M and Yang HT: ROS generated during early
reperfusion contribute to intermittent hypobaric hypoxia-afforded
cardioprotection against postischemia-induced Ca2+
overload and contractile dysfunction via the JAK2/STAT3 pathway. J
Mol Cell Cardiol. 81:150–161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ni CW, Hsieh HJ, Chao YJ and Wang DL:
Interleukin-6-induced JAK2/STAT3 signaling pathway in endothelial
cells is suppressed by hemodynamic flow. Am J Physiol Cell Physiol.
287:C771–C780. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fiaschi T, Magherini F, Gamberi T,
Lucchese G2, Faggian G2, Modesti A and Modesti PA: Hyperglycemia
and angiotensin II cooperate to enhance collagen I deposition by
cardiac fibroblasts through a ROS-STAT3-dependent mechanism.
Biochim Biophys Acta. 1843:2603–2610. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang T, Mao X, Li H, Qiao S, Xu A, Wang J,
Lei S, Liu Z, Ng KF, Wong GT, et al: N-Acetylcysteine and
allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via
adiponectin and attenuated myocardial postischemic injury in
diabetes. Free Radic Biol Med. 63:291–303. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hein TW, Xu W, Xu X and Kuo L: Acute and
chronic hyperglycemia elicit JIP1/JNK-mediated endothelial
vasodilator dysfunction of retinal arterioles. Invest Ophthalmol
Vis Sci. 57:4333–4340. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wu N, Shen H, Liu H, Wang Y, Bai Y and Han
P: Acute blood glucose fluctuation enhances rat aorta endothelial
cell apoptosis, oxidative stress and pro-inflammatory cytokine
expression in vivo. Cardiovasc Diabetol. 15:1092016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pollack RM, Donath MY, LeRoith D and
Leibowitz G: Anti-inflammatory agents in the treatment of diabetes
and its vascular complications. Diabetes Care. 39(Suppl 2):
S244–S252. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Halvorsen B, Santilli F, Scholz H,
Sahraoui A, Gulseth HL, Wium C, Lattanzio S, Formoso G, Di Fulvio
P, Otterdal K, et al: LIGHT/TNFSF14 is increased in patients with
type 2 diabetes mellitus and promotes islet cell dysfunction and
endothelial cell inflammation in vitro. Diabetologia. 59:2134–2144.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li Y, Zeng Z, Li Y, Huang W, Zhou M, Zhang
X and Jiang W: Angiotensin-converting enzyme inhibition attenuates
lipopoly-saccharide-induced lung injury by regulating the balance
between angiotensin-converting enzyme and angiotensin-converting
enzyme 2 and inhibiting mitogen-activated protein kinase
activation. Shock. 43:395–404. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gopallawa I and Uhal BD:
Angiotensin-(1-7)/mas inhibits apoptosis in alveolar epithelial
cells through upregulation of MAP kinase phosphatase-2. Am J
Physiol Lung Cell Mol Physiol. 310:L240–L248. 2016. View Article : Google Scholar
|
|
46
|
He J, Yang Z, Yang H, Wang L, Wu H, Fan Y,
Wang W, Fan X and Li X: Regulation of insulin sensitivity, insulin
production, and pancreatic β cell survival by angiotensin-(1-7) in
a rat model of streptozotocin-induced diabetes mellitus. Peptides.
64:49–54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Al-Maghrebi M and Renno WM: The
ACE/Angiotensin (1-7)/mas axis protects against testicular ischemia
reperfusion injury. Urology. 94:312.e1–8. 2016. View Article : Google Scholar
|
|
48
|
Yang HY, Bian YF, Zhang HP, Gao F, Xiao
CS, Liang B, Li J, Zhang NN and Yang ZM: Angiotensin-(1-7)
treatment ameliorates angiotensin II-induced apoptosis of human
umbilical vein endothelial cells. Clin Exp Pharmacol Physiol.
39:1004–1010. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ma X, Xu D, Ai Y, Zhao S, Zhang L, Ming G
and Liu Z: Angiotensin-(1-7)/mas signaling inhibits
lipopolysaccharide-induced ADAM17 shedding activity andapoptosis in
alveolar epithelial cells. Pharmacology. 97:63–71. 2016. View Article : Google Scholar
|
|
50
|
Kim CS, Kim IJ, Bae EH, Ma SK, Lee J and
Kim SW: Angiotensin-(1-7) attenuates kidney injury due to
obstructive nephropathy in rats. PLoS One. 10:e01426642015.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Meneses C, Morales MG, Abrigo J, Simon F,
Brandan E and Cabello-Verrugio C: The angiotensin-(1-7)/Mas axis
reduces myonuclear apoptosis during recovery from angiotensin
II-induced skeletal muscle atrophy in mice. Pflugers Arch.
46:1975–1984. 2015. View Article : Google Scholar
|
|
52
|
Lin L, Liu X, Xu J, Weng L, Ren J, Ge J
and Zou Y: Mas receptor mediates cardioprotection of
angiotensin-(1-7) against Angiotensin II-induced cardiomyocyte
autophagy and cardiac remodelling through inhibition of oxidative
stress. J Cell Mol Med. 20:48–57. 2016. View Article : Google Scholar
|
|
53
|
Shi Y, Lo CS, Padda R, Abdo S, Chenier I,
Filep JG, Ingelfinger JR, Zhang SL and Chan JS: Angiotensin-(1-7)
prevents systemic hypertension, attenuates oxidative stress and
tubulointerstitial fibrosis, and normalizes renal
angiotensin-converting enzyme 2 and Mas receptor expression in
diabetic mice. Clin Sci. 128:649–663. 2015. View Article : Google Scholar
|
|
54
|
McKinney CA, Fattah C, Loughrey CM,
Milligan G and Nicklin SA: Angiotensin-(1-7) and angiotensin-(1-9):
Function in cardiac and vascular remodelling. Clin Sci.
126:815–827. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ma Y, Huang H, Jiang J, Wu L, Lin C, Tang
A, Dai G, He J and Chen Y: AVE 0991 attenuates cardiac hypertrophy
through reducing oxidative stress. Biochem Biophys Res Commun.
474:621–625. 2016. View Article : Google Scholar
|
|
56
|
Zhang Y, Liu J, Luo JY, Tian XY, Cheang
WS, Xu J, Lau CW, Wang L, Wong WT, Wong CM, et al: Upregulation of
angiotensin (1-7)-mediated signaling preserves endothelial function
through reducing oxidative stress in diabetes. Antioxid Redox
Signal. 23:880–892. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhang F, Liu C, Wang L, Cao X, Wang YY and
Yang JK: Antioxidant effect of angiotensin (1-7) in the protection
of pancreatic β cell function. Mol Med Rep. 14:1963–1969. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Papinska AM, Mordwinkin NM, Meeks CJ,
Jadhav SS1 and Rodgers KE: Angiotensin-(1-7) administration
benefits cardiac, renal and progenitor cell function in db/db mice.
Br J Pharmacol. Jun 15–2015.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Li Y, Cao Y, Zeng Z, Liang M, Xue Y, Xi C,
Zhou M and Jiang W: Angiotensin-converting enzyme
2/angiotensin-(1-7)/Mas axis prevents lipopolysaccharide-induced
apoptosis of pulmonary microvascular endothelial cells by
inhibiting JNK/NF-κB pathways. Sci Rep. 5:82092015. View Article : Google Scholar
|
|
60
|
Zhang YH, Zhang YH, Dong XF, Hao QQ, Zhou
XM, Yu QT, Li SY, Chen X, Tengbeh AF, Dong B and Zhang Y: ACE2 and
Ang-(1-7) protect endothelial cell function and prevent early
atherosclerosis by inhibiting inflammatory response. Inflamm Res.
64:253–260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wang L, Hu X, Zhang W and Tian F:
Angiotensin (1-7) ameliorates angiotensin II-induced inflammation
by inhibiting LOX-1 expression. Inflamm Res. 62:219–228. 2013.
View Article : Google Scholar
|
|
62
|
Yu JW, Deng YP, Han X, Ren GF, Cai J and
Jiang GJ: Metformin improves the angiogenic functions of
endothelial progenitor cells via activating AMPK/eNOS pathway in
diabetic mice. Cardiovasc Diabetol. 15:882016. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Bretón-Romero R, Feng B, Holbrook M, Farb
MG, Fetterman JL, Linder EA, Berk BD, Masaki N, Weisbrod RM,
Inagaki E, et al: Endothelial dysfunction in human diabetes is
mediated by Wnt5a-JNK signaling. Arterioscler Thromb Vasc Biol.
36:561–569. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Haga S, Tsuchiya H, Hirai T, Hamano T,
Mimori A and Ishizaka Y: A novel ACE2 activator reduces
monocrotaline-induced pulmonary hypertension by suppressing the
JAK/STAT and TGF-β cascades with restored caveolin-1 expression.
Exp Lung Res. 41:21–31. 2015. View Article : Google Scholar
|
|
65
|
Lei Y, Xu Q, Zeng B, Zhang W, Zhen Y, Zhai
Y, Cheng F, Mei W, Zheng D, Feng J, et al: Angiotensin-(1-7)
protects cardiomyo-cytes against high glucose-induced injuries
through inhibiting reactive oxygen species-activated leptin-p38
mitogen-activated protein kinase/extracellular signal-regulated
protein kinase 1/2 pathways, but not the leptin-c-Jun N-terminal
kinase pathway in vitro. J Diabetes Investig. 8:434–445. 2017.
View Article : Google Scholar :
|
